All In Biotech

Drug Trial Radar · NCT07105371

Patients With ALS and Other Motor Disorders Will be Treated With Umbilical or Placental Mesenchymal Cell Exosome Solution

Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Jul 14, 2024

Primary completion

Oct 1, 2026

Study completion Oct 1, 2026

Sponsor

Lead sponsor
The Foundation for Orthopaedics and Regenerative MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.

Conditions

  • Motor Disorders

Interventions

  • Exosome SecretomeBiological

    This is an intranasal treatment of exosomes derived from Umbilical or Placental Derived Mesenchymal Stem Cells.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ALSFRS-R ResultsTime frame: from enrollment until 6 months after treatment

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Prodromos Stem Cell Institute

    Naples, Florida

  • Prodromos Stem Cell Institute

    Athens, Greece

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.